Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PET Imaging of Synaptic Density Combined With Neuroimmunologic Measures to Reveal Mechanisms of HIV Neuropathogenesis During ART

NCT05586581 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT05586581
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05586581 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PET Imaging of Synaptic Density Combined With Neuroimmunologic Measures to Reveal Mechanisms of HIV Neuropathogenesis During ART
Lead sponsor
Yale University
Phase
Phase 1/2
Overall status
Recruiting
Start date
May 17, 2023
Completion date
December 31, 2030
Enrollment
70 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy, hiv associated neurocognitive disorder, hiv dementia, hiv encephalitis